Science at Work
At Joslin Diabetes Research Center (DRC), our team is on a mission to improve care for patients around the globe - and we're making great headway in doing so. We're bringing new information from the laboratory bench directly to patients' bedsides in an effort to understand exactly what causes diabetes, and how lifestyle and medications can vastly improve quality of life.
Our institution is closely affiliated with Harvard Medical School and includes 14 full-time professors as well as more than 250 researchers in 30 research labs. We provide a facilitating framework for conducting multidisciplinary basic and clinical research and to encourage the scientific development of young investigators.
A Global Leader in Research
Scientists around the world look to Joslin to provide the latest diabetes research findings. Our work is supported by the National Institutes of Health and is changing how clinicians worldwide treat type 1 and type 2 diabetes.
Clinical Behavioral & Outcomes Research
The section on Clinical, Behavioral, and Outcomes Research aims to elucidate the underlying genetic and environmental determinants of type 1 and type 2 diabetes and its complications, and develop new treatments to prevent or delay the development of diabetes its complications in high-risk individuals.
Integrative Physiology & Metabolism
The Integrative Physiology & Metabolism Section has a focus on elucidating pathophysiological mechanisms in insulin resistance, obesity, and the development of type 2 diabetes, and determining how these conditions are modified by exercise, diet, and other factors.
More Joslin Sections